{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T08:16:35Z","timestamp":1695975395673},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This article discusses 2 specialized implantable cardioverter defibrillator (ICD) devices. A special type of implantable device is available for cardiac resynchronization therapy, which can also have a defibrillator, in which case it is called a CRT-D device. In patients who meet guidelines for eligibility, a CRT-D will diminish the number of significant cardiac events including death. A subcutaneous ICD device does not need any leads placed in the vascular system and therefore does not have some of the complications that may be seen with transvenous ICDs. Also, there are patients who are not candidates for a typical ICD implantation. On the other hand, there are important disadvantages to the subcutaneous ICD.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002136","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T21:31:40Z","timestamp":1526419900000},"page":"119-120","source":"Crossref","is-referenced-by-count":0,"title":["Quality and Safety in Health Care, Part XLIV"],"prefix":"10.1097","volume":"44","author":[{"given":"Jay A.","family":"Harolds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230928","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/CIRCULATIONAHA.115.020677","article-title":"Hospice use following implantable cardioverter-defibrillator implantation in older patients: results from the National Cardiovascular Data Registry","volume":"133","year":"2016","journal-title":"Circulation"},{"key":"bib3-20230928","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/CIRCULATIONAHA.116.022913","article-title":"Association between a prolonged PR interval and outcomes of cardiac resynchronization therapy. A report from the National Cardiovascular Data Registry","volume":"134","year":"2016","journal-title":"Circulation"},{"key":"bib7-20230928","first-page":"e644","article-title":"Subcutaneous implantable cardioverter-defibrillator","volume":"129","year":"2014","journal-title":"Circulation"},{"key":"bib8-20230928","first-page":"965","article-title":"Clinical outcomes of patients who received the subcutaneous implantable cardioverter defibrillator","volume":"1","year":"2016","journal-title":"JAMA Cardiol"},{"key":"bib10-20230928","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamacardio.2016.5388","article-title":"Use of cardiac resynchronization therapy among eligible patients receiving an implantable cardioverter defibrillator: insights from the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry","volume":"2","year":"2017","journal-title":"JAMA Cardiol"},{"key":"bib11-20230928","doi-asserted-by":"crossref","first-page":"e002324","DOI":"10.1161\/CIRCHEARTFAILURE.115.002324","article-title":"Comparative effectiveness of cardiac resynchronization therapy among patients with heart failure and atrial fibrillation: findings from the National Cardiovascular Data Registry\u2019s Implantable Cardioverter-Defibrillator Registry","volume":"9","year":"2016","journal-title":"Circ Heart Fail"},{"key":"bib12-20230928","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","year":"2016","journal-title":"JAMA Cardiol"},{"key":"bib13-20230928","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15420\/aer.2015.27.2","article-title":"Cardiac implantable electronic device infection in patients at risk","volume":"5","year":"2016","journal-title":"Arrhythm Electrophysiol Rev"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201902000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:19:49Z","timestamp":1695871189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201902000-00004"}},"subtitle":["Cardiac Resynchronization Therapy and Subcutaneous Defibrillator Implantable Devices"],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002136","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}